Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts

There are currently no reliable approaches for correctly identifying which patients with major depressive disorder (MDD) will respond well to antidepressant therapy. However, recent genetic advances suggest that Polygenic Risk Scores (PRS) could allow MDD patients to be stratified for antidepressant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Joey, Graham, Nicholas, Strawbridge, Rona J., Ferguson, Amy, Jenkins, Gregory, Chen, Wenan, Hodgson, Karen, Frye, Mark, Weinshilboum, Richard, Uher, Rudolf, Lewis, Cathryn M., Biernacka, Joanna, Smith, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150505/
https://www.ncbi.nlm.nih.gov/pubmed/30240446
http://dx.doi.org/10.1371/journal.pone.0203896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150505/
https://www.ncbi.nlm.nih.gov/pubmed/30240446
http://dx.doi.org/10.1371/journal.pone.0203896

Ejemplares similares